Alphamab Oncology (STU:3NK)
€ 0.428 -0.02 (-4.46%) Market Cap: 428.35 Mil Enterprise Value: 281.61 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 28/100

Alphamab Oncology (STU:3NK) Transcripts

    • 1